Companies · Retailing

royal wine medicine & food exhibition & marketing pte.ltd.

SINIGAPORE · Retailing

Diligence memoA one-page analyst read on royal wine medicine & food exhibition & marketing pte.ltd. — recommendation, valuation, rhythm, risks.→
$5.0M
Total raised · real
1
Rounds
—
Latest step-up
Top 29%
Sector rank · raised
Series A
Latest stage · inferred · Mon Dec 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

royal wine medicine & food exhibition & marketing pte.ltd. looks fair against its niche peers and is quiet on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the retail sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.77× the median modeled value of Series A Retailing companies in 2022–2024 (100 peers) — value vs value, same stage and era.
  • Within the normal band (77% of peer median) for its niche.
Quiet
  • Last raise 19 mo ago; this sector typically re-raises about every 13 months.
  • Slightly overdue versus sector cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Retailing

royal wine medicine & food exhibition & marketing pte.ltd. is one of 2347 Retailing companies tracked from SINIGAPORE. By capital raised it ranks in the upper tier (ahead of 72% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
$5M–$25M
Issuer revenue
Rule 504
Reg D exemption
2024-12-09
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$5.0M$10M$15M$20MSeries A · 2024-12-09 Raised $5.0M (real) Modeled valuation $14M (est)$5.0M$14MSeries A2024

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$5.0M · 2024

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 33%.

Modeled valuation trajectory
$13.9M
Base estimate est.
$6.1M
Conservative case
$27.2M
Upside case
$22.7M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series A — a $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the retail sector profile. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
50%
Survival probability
27% low · 68% high
1.15×/yr
Annual markup
1.45×/yr upside case
1.6 yr
Elapsed time used
1.6 yr actual, capped for stale marks
retail
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
—
Avg between rounds
—
Capital velocity
1.8 yr
On record since
2024
First round
1
Rounds on file
How it compares to the market

Benchmarked against 2347 companies in Retailing. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages)▲ 3.2× above median
This company$5.0M
Sector median$1.6M
Latest round — vs other Series A rounds in sector (real $, this stage)▼ 0.9× of median
This company$5.0M
Sector median$5.5M
Modeled value — vs sector median (estimate, all stages)▲ 2.4× above median
This company$13.9M
Sector median$5.8M

Raised more than 72% of sector peers (real $). Modeled value above 70% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #70 of 100.

This companyCohort peer
$10.0M$100.0M$1.0M$10.0M$100.0MCapital raised (log)Olivela Inc. · Series A Raised $28.8M · modeled $61.1M (est)PSP Investors, LLC · Series A Raised $15.4M · modeled $53.4M (est)Coreleap, Inc. · Series A Raised $16.7M · modeled $52.0M (est)Cariloha, Inc. · Series A Raised $22.5M · modeled $51.2M (est)Elevation Cannabis, LLC · Series A Raised $15.0M · modeled $47.6M (est)Botany Bay Wax Co LLC · Series A Raised $13.3M · modeled $45.8M (est)Full Glass Wine Co., LLC · Series A Raised $14.2M · modeled $44.2M (est)Kafene, Inc. · Series A Raised $42.1M · modeled $43.2M (est)Skinny Butcher LLC · Series A Raised $10.0M · modeled $41.6M (est)G2G Ventures, PBC · Series A Raised $13.4M · modeled $38.5M (est)YCP Car Wash Portfolio LLC · Series A Raised $12.6M · modeled $37.9M (est)Elevation Bridge, LLC · Series A Raised $12.0M · modeled $35.9M (est)royal wine medicine & food exhibition & marketing pte.ltd. (this company) Raised $5.0M · modeled $13.9M (est)royal wine medicine & food exhibition & marketing pte.ltd.
CompanyStageRaised · realValue · estvs peer med.
Olivela Inc.Series A$28.8M$61.1M3.35×
PSP Investors, LLCSeries A$15.4M$53.4M2.93×
Coreleap, Inc.Series A$16.7M$52.0M2.85×
Cariloha, Inc.Series A$22.5M$51.2M2.81×
Elevation Cannabis, LLCSeries A$15.0M$47.6M2.61×
Botany Bay Wax Co LLCSeries A$13.3M$45.8M2.52×
Full Glass Wine Co., LLCSeries A$14.2M$44.2M2.43×
Kafene, Inc.Series A$42.1M$43.2M2.37×
Skinny Butcher LLCSeries A$10.0M$41.6M2.29×
G2G Ventures, PBCSeries A$13.4M$38.5M2.12×
YCP Car Wash Portfolio LLCSeries A$12.6M$37.9M2.08×
Elevation Bridge, LLCSeries A$12.0M$35.9M1.97×
royal wine medicine & food exhibition & marketing pte.ltd. this companySeries A$5.0M$13.9M0.77×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$5.0M2024-12-09$22.7M$13.9M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$5.0M2024-12-09
    • First recorded raise — entered as Series A.
Intelligence
—
Modeled next raise
$8.0M
Modeled next size est.range $5.2M–$12.8M
—
Last step-up
—
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Sun Zhigang——2024-12
Registry & provenance

royal wine medicine & food exhibition & marketing pte.ltd. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
2019274
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Automated Retail Income Development, Inc.RetailingSeries A$5.0M$11.3Msame sector · same stage
Carolina Stc Investment Group, LlcRetailingSeries A$5.0M$11.3Msame sector · same stage
China Kangmao Group LtdRetailingSeries A$5.0M$13.4Msame sector · same stage
Dongfox Enterprises LtdRetailingSeries A$5.0M$11.7Msame sector · same stage
ETERNAL STAR GLOBAL LtdRetailingSeries A$5.0M$13.2Msame sector · same stage
Handpicked, LLCRetailingSeries A$5.0M$11.3Msame sector · same stage
Hearing Help Express, Inc.RetailingSeries A$5.0M$11.3Msame sector · same stage
Henderson Distilling Company, LLCRetailingSeries A$5.0M$17.1Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Coda Wines, Inc.RetailingPre-Seed$1.7M80%
Dedalus Wine Group Inc.RetailingSeed$13.2M79%
Full Glass Wine Co., LLCRetailingSeries A$44.2M79%
Wine Retriever LLCRetailingPre-Seed$785K78%
NQOCD Consulting LtdRetailingPre-Seed$477K78%
Roxberry Naturals, Inc.RetailingPre-Seed$2.4M77%
Very Good Food & Beverage LtdRetailingSeries A$13.2M77%
Pop & Bottle, Inc.RetailingSeries A$8.6M77%
Frequently asked
How much funding has royal wine medicine & food exhibition & marketing pte.ltd. raised?
royal wine medicine & food exhibition & marketing pte.ltd. has raised approximately $5.0M in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is royal wine medicine & food exhibition & marketing pte.ltd.'s estimated valuation?
Provath's modeled valuation for royal wine medicine & food exhibition & marketing pte.ltd. is approximately $13.9M (modeled range $6.1M–$27.2M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is royal wine medicine & food exhibition & marketing pte.ltd. at?
royal wine medicine & food exhibition & marketing pte.ltd.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Mon Dec 09.
What does royal wine medicine & food exhibition & marketing pte.ltd. do and where is it based?
royal wine medicine & food exhibition & marketing pte.ltd. operates in the Retailing sector, based in SINIGAPORE.
Explore related

See where royal wine medicine & food exhibition & marketing pte.ltd. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at royal wine medicine & food exhibition & marketing pte.ltd., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.